HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neha Korde Selected Research

IPH-2101

11/2016Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma.
6/2014A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Neha Korde Research Topics

Disease

51Multiple Myeloma
05/2024 - 01/2011
13Smoldering Multiple Myeloma
11/2022 - 06/2014
12Residual Neoplasm
11/2023 - 01/2014
10Neoplasms (Cancer)
05/2024 - 10/2011
6Monoclonal Gammopathy of Undetermined Significance
09/2019 - 03/2012
3Infections
02/2024 - 06/2021
3Neutropenia
02/2024 - 01/2021
3COVID-19
01/2021 - 06/2020
3Paraproteinemias (Monoclonal Gammopathy)
04/2016 - 10/2011
3Disease Progression
03/2016 - 10/2014
2Venous Thromboembolism
03/2024 - 01/2022
2Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 03/2012
2Hypertension (High Blood Pressure)
11/2020 - 06/2020
2Cardiotoxicity
11/2018 - 01/2018
1Cytokine Release Syndrome
04/2024
1Venous Thrombosis (Deep-Vein Thrombosis)
03/2024
1Myocardial Infarction
03/2024
1Ischemic Stroke
03/2024
1Thromboembolism
03/2024
1Pulmonary Embolism
03/2024
1Agammaglobulinemia (Hypogammaglobulinemia)
02/2024
1Breakthrough Infections
11/2023
1Proteinuria
01/2023
1Immunoglobulin Light-chain Amyloidosis
01/2023
1Hemorrhage
01/2022
1Exanthema (Rash)
06/2021
1Respiratory Insufficiency (Respiratory Failure)
01/2021
1Hypoalbuminemia
10/2019
1Hyperbilirubinemia
10/2019
1Obesity
01/2017
1Overweight
01/2017
1Leukemia
11/2016
1Amyloidosis
04/2016
1Acute Kidney Injury (Acute Renal Failure)
03/2016

Drug/Important Bio-Agent (IBA)

19Lenalidomide (CC 5013)FDA Link
03/2024 - 03/2012
18Dexamethasone (Maxidex)FDA LinkGeneric
03/2024 - 09/2015
17carfilzomibIBA
03/2024 - 09/2015
6Proteins (Proteins, Gene)FDA Link
05/2021 - 10/2011
5bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
05/2024 - 01/2022
5Bortezomib (Velcade)FDA Link
03/2024 - 06/2021
5daratumumabIBA
11/2023 - 05/2021
5Melphalan (Alkeran)FDA LinkGeneric
06/2021 - 10/2011
5Immunoglobulin G (IgG)IBA
11/2020 - 10/2011
5Biomarkers (Surrogate Marker)IBA
09/2019 - 08/2014
4B-Cell Maturation AntigenIBA
05/2024 - 10/2023
4Monoclonal AntibodiesIBA
11/2023 - 05/2021
4Proteasome InhibitorsIBA
06/2021 - 08/2014
3Immunomodulating AgentsIBA
01/2021 - 10/2011
3Proteasome Endopeptidase Complex (Proteasome)IBA
01/2017 - 08/2014
3Immunoglobulin A (IgA)IBA
04/2016 - 10/2011
3Immunoglobulin M (IgM)IBA
06/2014 - 10/2011
2DNA (Deoxyribonucleic Acid)IBA
05/2024 - 01/2022
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
05/2024 - 01/2011
2Chimeric Antigen ReceptorsIBA
04/2024 - 10/2020
2ixazomibIBA
11/2022 - 01/2020
2AnticoagulantsIBA
01/2022 - 05/2015
2Immunoglobulins (Immunoglobulin)IBA
12/2019 - 01/2011
2IPH-2101IBA
11/2016 - 06/2014
1belantamab mafodotinIBA
05/2024
1insulin receptor-related receptor (IRR)IBA
02/2024
1AntibodiesIBA
11/2023
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2023
1RNA (Ribonucleic Acid)IBA
11/2023
1cilgavimabIBA
11/2023
1tixagevimabIBA
11/2023
1cilgavimab and tixagevimab drug combinationIBA
11/2023
1VaccinesIBA
11/2023
1Amyloid (Amyloid Fibrils)IBA
01/2023
1Butyrates (Butyrate)IBA
12/2022
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2022
1RivaroxabanIBA
01/2022
1Alanine Transaminase (SGPT)IBA
06/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021
1trans-crotonin (CTN)IBA
10/2020
1selinexorIBA
01/2020
1Complementarity Determining Regions (Complementarity Determining Region)IBA
12/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2018
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2018
1Chemokine ReceptorsIBA
01/2017
1ChymotrypsinFDA Link
01/2017
1Hormones (Hormone)IBA
01/2017
1TrypsinIBA
01/2017
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2017
1plerixaforFDA Link
01/2017
1CaspasesIBA
01/2017
1AdiponectinIBA
01/2017
1cabozantinibIBA
12/2016
1LigandsIBA
11/2016
1Immune Checkpoint InhibitorsIBA
11/2016

Therapy/Procedure

29Therapeutics
05/2024 - 03/2013
3Immunotherapy
11/2023 - 11/2016
3Stem Cell Transplantation
09/2022 - 10/2011
2Drug Therapy (Chemotherapy)
06/2021 - 01/2021
2Artificial Respiration (Mechanical Ventilation)
11/2020 - 06/2020
2Hematopoietic Stem Cell Mobilization
01/2020 - 01/2017
1Plant-Based Diet
12/2022
1Transplantation
01/2020
1Lasers (Laser)
01/2020
1Hematopoietic Stem Cell Transplantation
11/2016